Senseonics Holdings, Inc. reported significant financial developments in its latest 10-Q filing for the quarter ending September 30, 2025. The company achieved total revenue of $8.1 million, a substantial increase from $4.3 million in the same period last year, driven primarily by growth in its consignment program and demand for its Eversense 365 product. The revenue from related parties, particularly from Ascensia, accounted for $3.9 million, reflecting a slight increase from $3.3 million in the prior year. The gross profit for the quarter was $3.5 million, a notable recovery from a loss of $4.1 million in the previous year, resulting in a gross margin of 42.8%.
In terms of expenses, Senseonics reported a decrease in research and development costs to $7.8 million from $10.5 million year-over-year, attributed to the completion of clinical trials for the Eversense 365 system. However, selling, general, and administrative expenses rose to $15.3 million, up from $8.3 million, largely due to increased promotional spending and sales commissions. The company recorded an operating loss of $19.6 million, an improvement from a loss of $22.8 million in the same quarter of 2024.
Operationally, Senseonics is transitioning its commercial operations back from Ascensia, with a memorandum of understanding signed on September 3, 2025, to facilitate this process. This transition is expected to take effect on January 1, 2026, and will allow the company to have greater control over its revenue generation and market adoption strategies. The company has also expanded its consignment sales model, which accounted for 46.5% of total revenue in the latest quarter, up from 20.1% in the previous year.
As of September 30, 2025, Senseonics reported total assets of $139.9 million, with cash and cash equivalents amounting to $34.5 million, a decrease from $74.6 million at the end of 2024. The company’s total liabilities decreased to $61.8 million from $79.3 million, primarily due to the repayment of debt. Despite these improvements, Senseonics continues to face challenges, including a net loss of $19.5 million for the quarter and an accumulated deficit of $996.2 million. The company has indicated that it will require additional funding to sustain operations and support its growth initiatives, particularly as it navigates the transition of commercial operations and seeks to enhance the adoption of its Eversense systems.
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc. develops and manufactures long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its flagship product, Eversense, offers up to one-year sensor life, real-time glucose data via a mobile app, and safety alerts. The company partners with distributors and healthcare providers worldwide, focusing on regulatory approvals, reimbursement, and expanding access through strategic collaborations and innovative product development.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.